دورية أكاديمية
أعرض في EDS

Plasma Intercellular Adhesion Molecule-1 and von Willebrand Factor in Primary Graft Dysfunction After Lung Transplantation

التفاصيل البيبلوغرافية
العنوان: Plasma Intercellular Adhesion Molecule-1 and von Willebrand Factor in Primary Graft Dysfunction After Lung Transplantation
المؤلفون: Covarrubias, M., Ware, L. B., Kawut, S. M., De Andrade, J., Milstone, A., Weinacker, A., Orens, J., Lama, V. N., Wille, K., Bellamy, Scarlett, Shah, Chirag V., Demissie, E., Christie, Jason D.
المساهمون: Division of Allergy, Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University, Nashville, TN, Division of Allergy, Pulmonary and Critical Care Medicine, Columbia University, College of Physicians and Surgeons, New York, NY, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, Division of Pulmonary and Critical Care Medicine, University of Alabama, Birmingham, AL, Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA, Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University Hospital, Baltimore, MD, Department of Biostatistics and Epidemiology and, Division of Allergy, Pulmonary and Critical Care Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA
بيانات النشر: Blackwell Publishing Ltd
سنة النشر: 2007
المجموعة: University of Michigan: Deep Blue
مصطلحات موضوعية: Epidemiology, Human, Injury Mechanisms and Biomarkers, Ischemia/Reperfusion Injury, Lung Transplantation, Translational Research, Medicine (General), Health Sciences
الوصف: Peer Reviewed ; http://deepblue.lib.umich.edu/bitstream/2027.42/75029/1/j.1600-6143.2007.01981.x.pdfTest
نوع الوثيقة: article in journal/newspaper
وصف الملف: 129593 bytes; 3109 bytes; application/pdf; text/plain
اللغة: unknown
تدمد: 1600-6135
1600-6143
العلاقة: Covarrubias, M.; Ware, L. B.; Kawut, S. M.; De Andrade, J.; Milstone, A.; Weinacker, A.; Orens, J.; Lama, V.; Wille, K.; Bellamy, S.; Shah, C.; Demissie, E.; Christie, J. D. (2007). "Plasma Intercellular Adhesion Molecule-1 and von Willebrand Factor in Primary Graft Dysfunction After Lung Transplantation." American Journal of Transplantation 7(11): 2573-2578.; https://hdl.handle.net/2027.42/75029Test; http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17908278&dopt=citationTest; American Journal of Transplantation; Carter YM, Davis RD. Primary graft dysfunction in lung transplantation. Semin Respir Crit Care Med 2006; 27: 501 – 507.; Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24: 1454 – 1459.; Christie JD, Van Raemdonck D, de Perrot M et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: Introduction and methods. J Heart Lung Transplant 2005; 24: 1451 – 1453.; Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: Twenty-third official adult lung and heart-lung transplantation report—2006. J Heart Lung Transplant 2006; 25: 880 – 892.; Barr ML, Kawut SM, Whelan TP et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: Recipient-related risk factors and markers. J Heart Lung Transplant 2005; 24: 1468 – 1482.; Christie JD, Kotloff RM, Pochettino A et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003; 124: 1232 – 1241.; de Perrot M, Bonser RS, Dark J et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: Donor-related risk factors and markers. J Heart Lung Transplant 2005; 24: 1460 – 1467.; Thabut G, Mal H, Cerrina J, et al. Influence of donor characteristics on outcome after lung transplantation: A multicenter study. J Heart Lung Transplant 2005; 24: 1347 – 1353.; Conner ER, Ware LB, Modin G, Matthay MA. Elevated pulmonary edema fluid concentrations of soluble intercellular adhesion molecule-1 in patients with acute lung injury: Biological and clinical significance. Chest 1999; 116 ( 1 Suppl ): 83S – 84S.; Flori HR, Ware LB, Glidden D, Matthay MA. Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation. Pediatr Crit Care Med 2003; 4: 315 – 321.; Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997; 96: 1102 – 1108.; Kawut SM, Horn EM, Berekashvili KK, Widlitz AC, Rosenzweig EB, Barst RJ. von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension. Chest 2005; 128: 2355 – 2362.; Morange PE, Simon C, Alessi MC et al. Endothelial cell markers and the risk of coronary heart disease: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 2004; 109: 1343 – 1348.; Rubin DB, Wiener-Kronish JP, Murray JF et al. Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990; 86: 474 – 480.; Ware LB, Conner ER, Matthay MA. von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med 2001; 29: 2325 – 2331.; Ware LB, Eisner MD, Thompson BT, Parsons PE, Matthay MA. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 2004; 170: 766 – 772.; Christie JD, Robinson N, Ware LB et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am J Respir Crit Care Med 2007; 175: 69 – 74.; Egan TM, Thomas Y, Gibson D et al. Trigger for intercellular adhesion molecule-1 expression in rat lungs transplanted from non-heart-beating donors. Ann Thorac Surg 2004; 77: 1048 – 1055.; Toda K, Kayano K, Karimova A et al. Antisense intercellular adhesion molecule-1 (ICAM-1) oligodeoxyribonucleotide delivered during organ preservation inhibits posttransplant ICAM-1 expression and reduces primary lung isograft failure. Circ Res 2000; 86: 166 – 174.; Kato GJ, Martyr S, Blackwelder WC et al. Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. Br J Haematol 2005; 130: 943 – 953.; Ware LB, Golden JA, Finkbeiner WE, Matthay MA. Alveolar epithelial fluid transport capacity in reperfusion lung injury after lung transplantation. Am J Respir Crit Care Med 1999; 159: 980 – 988.; Prekker ME, Nath DS, Walker AR et al. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant 2006; 25: 371 – 378.; Krenn K, Klepetko W, Taghavi S, Lang G, Schneider B, Aharinejad S. Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction. Am J Transplant 2007; 7: 700 – 706.
DOI: 10.1111/j.1600-6143.2007.01981.x
الإتاحة: https://doi.org/10.1111/j.1600-6143.2007.01981.xTest
https://hdl.handle.net/2027.42/75029Test
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17908278&dopt=citationTest
رقم الانضمام: edsbas.135B0FD4
قاعدة البيانات: BASE
الوصف
تدمد:16006135
16006143
DOI:10.1111/j.1600-6143.2007.01981.x